IGM Biosciences

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGMS and other ETFs, options, and stocks.

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.

CEO

Fred M. Schwarzer

CEOFred M. Schwarzer

Employees

192

Employees192

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

2010

Founded2010

Employees

192

Employees192

IGMS Key Statistics

Market cap

827.12M

Market cap827.12M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

201.56K

Average volume201.56K

High today

$20.73

High today$20.73

Low today

$19.27

Low today$19.27

Open price

$20.73

Open price$20.73

Volume

151.48K

Volume151.48K

52 Week high

$72.94

52 Week high$72.94

52 Week low

$12.67

52 Week low$12.67

Analyst ratings

80%

of 10 ratings

Buy

80%

Hold

20%

Sell

IGMS Earnings

-$1.61

-$1.07

-$0.54

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, After Hours

ActualExpected Nov 3, After Hours